We are a contract research organization
Offering cutting-edge research services and consultancy in the field of liver diseases
We provide tailored reliable solutions to our partners for successful strategic decision making
Previous
Next

The complete pre-clinical Solution

Our services

BLB is a contract research organization that offers cutting-edge research services
and consultancy in the field of liver diseases.

We provide tailored reliable solutions to our partners for successful
strategic decision making

EXOLIVER®

BLB offers you the possibility to test your drug candidates in a human liver biological system: the unique and patent-protected ExoLiver platform
MORE INFO

TISSUES

BLB gives you the possibility to analyze your favourite gene or protein in liver tissue obtained from rodents and humans
MORE INFO

ORGAN
ON A CHIP

BLB offers high-quality services to create tailored organ on a chip platforms for preclinical human disease modelling
MORE INFO

RODENT
MODELS

BLB provides research services using topquality pre-clinical models of liver disease, including liver cirrhosis, cholestatic liver disease & NASH
MORE INFO

LIVER
CELLS

BLB develops analysis with highly pure and viable rodent and human primary liver cells
MORE INFO

STRATEGIC
CONSULTANCY

The virtuous combination of having deep experience in both pre-clinical and clinical phases of liver research
MORE INFO

News

Introducing the BarNa model®: BLB’s pre-clinical model of NASH

Barcelona Liver Bioservices (BLB), CRO specialized in liver diseases, announced today the publication of the manuscript entitled “New Rat Model of Advanced NASH Mimicking Pathophysiological Features and Transcriptomic Signature of The Human Disease” in the peer-reviewed journal Cells.

Our partners

Proudly supported by partners and collaborators as

BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.

BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers